USPTO 2015–2025 USPTO PatentsView US Corporation

Decision Sciences Medical Company, LLC

USPTO PatentsView assignee record - 15 granted patents across 13 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Decision ranks #18,530 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 13 technology areas.

#18,530
of 49,997 US assignees by volume
Top 19%
by Innovation Score (47.3/100)
25.1
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18530 · US Corporation #18,530 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,530/49,997
  • PHOTO-FINISH Daedong Industrial
  • CPC-FOCUS A61B · 13 areas
  • INNOV-PAR 47.3/100
  • CLAIMS-DENSE 25.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Daedong Industrial Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Decision’s 47.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Decision

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Decision's Innovation Score is 47.3/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Decision?

Each dot is one of Decision’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Decision’s own 25.1 claims/patent is ABOVE the 10.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Decision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 0102030 Granted patents (volume) Avg claims / patent Daedong Industrial Co., Ltd. - 15, 6.8Daedong IndustrialDalian Research Institute OF Petroleum AND Petrochemicals, Sinopec Corp. - 15, 17.33Dalian Research I…Dankook University Cheonan Campus Industry Academic Cooperation Foundation - 15, 10.93Dankook Universit…DCG Systems, Inc. - 15, 19.33DCG SystemsDelsey - 15, 2.13DelseyDexcel Pharma Technologies Ltd. - 15, 19.07Dexcel PharmaDialpad, Inc. - 15, 19.33DialpadDIC Corporation (TOKYO) - 15, 8.47DIC (Tokyo)Decision Sciences Medical Company, LLC - 15, 25.13Decision Sciences…
Decision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Decision's grants concentrate

Decision Sciences Medical Company, LLC is a focused PatentsView assignee: 13 CPC subclasses with 93.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2019. By volume, Decision sits between Daedong Industrial Co., Ltd. and DIC Corporation (TOKYO).

Decision's three-year grant acceleration

Decision Sciences Medical Company, LLC shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Decision's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Decision holds 15 patents at rank #18,525, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Decision

By rank, the assignees closest to #18,525 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Decision's primary technology class.

Decision's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20172019202020212022202320242025 3
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Decision Sciences Medical Company, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 13.3%
2019 1 6.7%
2020 1 6.7%
2021 2 13.3%
2022 1 6.7%
2023 2 13.3%
2024 3 20.0%
2025partial year 3 20.0%

Which technologies does Decision Sciences Medical Company, LLC patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Decision Sciences Medical Company, LLC's patent record in context - here's where to go next.

  • Decision Sciences Medical Company, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 93.3% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #18,530 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Decision Sciences Medical Company, LLC against Daedong Industrial Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.